17185
2017
eng
11160-11172
7
8
article
1
2018-11-15
--
--
Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cell lines and are potential targets for therapy
The MuvB multiprotein complex, together with B-MYB and FOXM1 (MMB-FOXM1), plays an essential role in cell cycle progression by regulating the transcription of genes required for mitosis and cytokinesis. In many tumors, B-MYB and FOXM1 are overexpressed as part of the proliferation signature. However, the transcriptional targets that are important for oncogenesis have not been identified. Given that mitotic kinesins are highly expressed in cancer cells and that selected kinesins have been reported as target genes of MMB-FOXM1, we sought to determine which mitotic kinesins are directly regulated by MMB-FOXM1. We demonstrate that six mitotic kinesins and two microtubule-associated non-motor proteins (MAPs) CEP55 and PRC1 are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cells.
Suppression of KIF23 and PRC1 strongly suppressed proliferation of MDA-MB-231 cells. The set of MMB-FOXM1 regulated kinesins genes and 4 additional kinesins which we referred to as the mitotic kinesin signature (MKS) is linked to poor outcome in breast cancer patients. Thus, mitotic kinesins could be used as prognostic biomarker and could be potential therapeutic targets for the treatment of breast cancer.
Oncotarget
10.18632/oncotarget.14466
28061449
urn:nbn:de:bvb:20-opus-171851
Oncotarget (2017) 8:7, pp. 11160-11172. https://doi.org/10.18632/oncotarget.14466
true
true
Patrick Wolter
Steffen Hanselmann
Grit Pattschull
Eva Schruf
Stefan Gaubatz
eng
uncontrolled
breast cancer
eng
uncontrolled
kinesin
eng
uncontrolled
cell cycle
eng
uncontrolled
cytokinesis
Medizin und Gesundheit
open_access
Theodor-Boveri-Institut für Biowissenschaften
Medizinische Klinik und Poliklinik II
Universität Würzburg
https://opus.bibliothek.uni-wuerzburg.de/files/17185/Wolter_14466-215090-2-PB.pdf
6229
2010
eng
article
1
2012-10-30
--
--
MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation
Background: Melanoma cells are usually characterized by a strong proliferative potential and efficient invasive migration. Among the multiple molecular changes that are recorded during progression of this disease, aberrant activation of receptor tyrosine kinases (RTK) is often observed. Activation of matrix metalloproteases goes along with RTK activation and usually enhances RTK-driven migration. The purpose of this study was to examine RTKdriven three-dimensional migration of melanocytes and the pro-tumorigenic role of matrix metalloproteases for melanocytes and melanoma cells. Results: Using experimental melanocyte dedifferentiation as a model for early melanomagenesis we show that an activated EGF receptor variant potentiates migration through three-dimensional fibrillar collagen. EGFR stimulation also resulted in a strong induction of matrix metalloproteases in a MAPK-dependent manner. However, neither MAPK nor MMP activity were required for migration, as the cells migrated in an entirely amoeboid mode. Instead, MMPs fulfilled a function in cell cycle regulation, as their inhibition resulted in strong growth inhibition of melanocytes. The same effect was observed in the human melanoma cell line A375 after stimulation with FCS. Using sh- and siRNA techniques, we could show that MMP13 is the protease responsible for this effect. Along with decreased proliferation, knockdown of MMP13 strongly enhanced pigmentation of melanocytes. Conclusions: Our data show for the first time that growth stimuli are mediated via MMP13 in melanocytes and melanoma, suggesting an autocrine MMP13-driven loop. Given that MMP13-specific inhibitors are already developed, these results support the evaluation of these inhibitors in the treatment of melanoma.
urn:nbn:de:bvb:20-opus-68335
6833
In: Molecular Cancer (2010) 9, DOI: 10.1186/1476-4598-9-201
Svenja Meierjohann
Anita Hufnagel
Elisabeth Wende
Markus A. Kleinschmidt
Katarina Wolf
Peter Friedl
Stefan Gaubatz
Manfred Schartl
deu
swd
Medizin
Biowissenschaften; Biologie
open_access
Theodor-Boveri-Institut für Biowissenschaften
Universität Würzburg
https://opus.bibliothek.uni-wuerzburg.de/files/6229/Meierjohann058_1476_4598_9_201.pdf
9692
2013
eng
article
1
--
--
--
LIN9, a Subunit of the DREAM Complex, Regulates Mitotic Gene Expression and Proliferation of Embryonic Stem Cells
The DREAM complex plays an important role in regulation of gene expression during the cell cycle. We have previously shown that the DREAM subunit LIN9 is required for early embryonic development and for the maintenance of the inner cell mass in vitro. In this study we examined the effect of knocking down LIN9 on ESCs. We demonstrate that depletion of LIN9 alters the cell cycle distribution of ESCs and results in an accumulation of cells in G2 and M and in an increase of polyploid cells. Genome-wide expression studies showed that the depletion of LIN9 results in downregulation of mitotic genes and in upregulation of differentiation-specific genes. ChIP-on chip experiments showed that mitotic genes are direct targets of LIN9 while lineage specific markers are regulated indirectly. Importantly, depletion of LIN9 does not alter the expression of pluripotency markers SOX2, OCT4 and Nanog and LIN9 depleted ESCs retain alkaline phosphatase activity. We conclude that LIN9 is essential for proliferation and genome stability of ESCs by activating genes with important functions in mitosis and cytokinesis.
PLoS ONE
10.1371/journal.pone.0062882
urn:nbn:de:bvb:20-opus-96922
In: PLoS One (2013) 8: 5, doi:10.1371/journal.pone.0062882
Stefan Gaubatz
Jasmina Esterlechner
Nina Reichert
Fabian Iltzsche
Michael Krause
Florian Finkernagel
eng
uncontrolled
cell cycle
eng
uncontrolled
cell division
eng
uncontrolled
cell differentation
eng
uncontrolled
DNA-binding proteins
eng
uncontrolled
gene expression
eng
uncontrolled
gene regulation
eng
uncontrolled
gene targeting
eng
uncontrolled
microarrays
eng
uncontrolled
pluripotency
Biowissenschaften; Biologie
open_access
Theodor-Boveri-Institut für Biowissenschaften
Förderzeitraum 2013
Universität Würzburg
https://opus.bibliothek.uni-wuerzburg.de/files/9692/Gaubatz_journal.pone.0062882.pdf
20203
2019
eng
3533-3546
12
27
article
1
2020-03-17
--
--
The Myb-MuvB complex is required for YAP-dependent transcription of mitotic genes
YAP and TAZ, downstream effectors of the Hippo pathway, are important regulators of proliferation. Here, we show that the ability of YAP to activate mitotic gene expression is dependent on the Myb-MuvB (MMB) complex, a master regulator of genes expressed in the G2/M phase of the cell cycle. By carrying out genome-wide expression and binding analyses, we found that YAP promotes binding of the MMB subunit B-MYB to the promoters of mitotic target genes. YAP binds to B-MYB and stimulates B-MYB chromatin association through distal enhancer elements that interact with MMB-regulated promoters through chromatin looping. The cooperation between YAP and B-MYB is critical for YAP-mediated entry into mitosis. Furthermore, the expression of genes coactivated by YAP and B-MYB is associated with poor survival of cancer patients. Our findings provide a molecular mechanism by which YAP and MMB regulate mitotic gene expression and suggest a link between two cancer-relevant signaling pathways.
Cell Reports
10.1016/j.celrep.2019.05.071
urn:nbn:de:bvb:20-opus-202039
Cell Reports (2019) 27:12, 3533-3546. https://doi.org/10.1016/j.celrep.2019.05.071
false
true
CC BY-NC-ND: Creative-Commons-Lizenz: Namensnennung, Nicht kommerziell, Keine Bearbeitungen 4.0 International
Grit Pattschull
Susanne Walz
Marco Gründl
Melissa Schwab
Eva Rühl
Apoorva Baluapuri
Anita Cindric-Vranesic
Susanne Kneitz
Elmar Wolf
Carsten P. Ade
Andreas Rosenwald
Björn von Eyss
Stefan Gaubatz
eng
uncontrolled
YAP
eng
uncontrolled
B-MYB
eng
uncontrolled
Myb-MuvB
eng
uncontrolled
mitotic genes
eng
uncontrolled
enhancer
eng
uncontrolled
transcription
Biowissenschaften; Biologie
open_access
Pathologisches Institut
Theodor-Boveri-Institut für Biowissenschaften
Deutsches Zentrum für Herzinsuffizienz (DZHI)
Förderzeitraum 2019
Universität Würzburg
https://opus.bibliothek.uni-wuerzburg.de/files/20203/Pattschull_CellReports_2019.pdf